Posts by Jagpreet Chhatwal, PhD
County-level COVID-19 Data Confirms Effectiveness of Workplace Closure
Jagpreet Chhatwal, PhD, a senior decision scientist at the Massachusetts General Hospital Institute for Technology Assessment, and colleagues have created an open-source dataset that permits research into how non-pharmaceutical interventions affect COVID-19 rates.
COVID-19 Simulator Informs Local Policymaking: Q&A with Jagpreet Chhatwal, PhD
The COVID-19 Simulator was launched in April 2020 to help health policymakers and practitioners make decisions regarding policy and strategy related to the novel coronavirus pandemic. The new tools further provide insights into local-level COVID-19 outbreaks and how far are we from reaching herd immunity.
New COVID-19 Simulator Aims to Guide State Back-to-Work Planning
Researchers at Massachusetts General Hospital and Georgia Tech have developed an online tool that can help policymakers make effective public health decisions surrounding the coronavirus (COVID-19) pandemic.
Early Transplantation for Alcohol-associated Hepatitis Improves Survival
According to a mathematical model, offering liver transplantation with no minimum period of sobriety before surgery (i.e., early liver transplantation) for severe alcohol-associated hepatitis provides a fourfold increase in life expectancy compared with requiring a six-month period of sobriety before listing. having characteristics similar to patients in ACCELERATE-AH trial.
U.S. Not on Track to Meet WHO's Hepatitis C Elimination Targets
Using computer modeling, researchers at Massachusetts General Hospital project that the U.S. is behind schedule to meet the World Health Organization's goal of having 90% of hepatitis C infections diagnosed by 2030.
Bariatric Surgery May Be Cost-Effective for Obese Patients with NASH Cirrhosis
Based on the first cost-effectiveness study of weight loss therapies among patients with nonalcoholic steatohepatitis cirrhosis, researchers at Massachusetts General Hospital recommend considering bariatric surgery as appropriate.
Dr. Chhatwal is an assistant professor at Harvard Medical School and associate director of the MGH Institute for Technology Assessment (ITA). His research is centered in decision science, data analytics, outcomes research and health economics. He has over 10 years of experience in developing decision-analytic models to evaluate disease outcomes. He currently leads research in multiple disease areas including substance use disorder (opioids and alcohol), liver diseases (hepatitis C, liver cancer, nonalcoholic fatty liver disease) and anal cancer.